Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers December 15, 2018
Pharmacy Choice - News - Front Page Healthcare News - December 15, 2018

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/15/18 - Access Strategy Partners Inc Helps Improve Access to New Medical Technologies for Healthcare Providers [Tehran Times (Iran)]
-Access Strategy Partners Inc today announces the launch of its new platform that aligns medical device companies with healthcare providers and supply chain organizations to simplify the acquisition of leading-edge technologies. This new global enterprise will prepare small and mid-size device companies for successful commercial engagement with...
12/15/18 - Ambulatory Care Market to Witness an Outstanding Growth by 2026
Albany, NY 12/14/2018 Ambulatory care, also known as outpatient care, is medical care provided on an outpatient basis, including observation, consultation, diagnosis, rehabilitation, intervention, and treatment services. Ambulatory care includes primary care, ambulatory surgery, emergency care, and others. Ambulatory surgery is defined as sur
12/15/18 - AstraZeneca mines for positives in Imfinzi`s failed Mystic lung cancer trial [Syrian Arab News Agency]
AstraZeneca felt the blow last month when Mystic, a key trial examining its immuno-oncology drug Imfinzi in previously untreated lung cancer, failed. As executives were quick to point out, there was clear clinical benefit of Imfinzi monotherapy compared with the standard of care in the phase 3 trial, which featured patients whose tumors expressed p
12/15/18 - BeiGene Announces Updated Phase 1A/1B Data on Tislelizumab Presented at the European Society for Medical Oncology Immuno-Oncology Congress
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, announced that updated clinical data from an ongoing Phase 1 A/1B trial of tislelizumab, an investigational anti-PD-1 antibody, were presented in an oral...
12/15/18 - Bevacizumab Biosimilar, IBI305, Meets Primary End Points in 2 Clinical Trials [T-break Tech (Middle East)]
"Lung cancer is the highest incidence cancer in China, and bevacizumab is an important treatment for non-small lung cancer patients. The launch of a high-quality bevacizumab biosimilar will improve drug accessibility and benefit more patients, "said Li Zhang, MD, from the cancer hospital of Sun Yat-Sen University, in a statement announcing the posi
12/15/18 - Bovine Blood Plasma Derivatives Market Will Increment at a Notable CAGR of 5.8% During the Forecast Period of 2017 to 2025
Albany, NY 12/14/2018 Global Bovine Blood Plasma Derivatives Market: Snapshot. Bovine blood plasma derivatives are exclusive in a way when it comes to delivering palatability, something that cannot be achieved via other alternatives such as plant extracted proteins and other synthetic nutrient elements. The analysts of the report have evaluat
12/15/18 - Butantan Institute and MSD agree to collaborate on dengue vaccine development [T-break Tech (Middle East)]
Brazil`s Butantan Institute signed a collaboration agreement with Merck Sharp& Dohme to develop dengue vaccines. The vaccine developed by Butantan Institute with So Paulo Research Foundation- FAPESP`s support is currently in the last phase of trials involving humans, with 17,000 volunteers participating. The agreement also allows for exclusive...
12/15/18 - Center for American Progress Issues Statement on Court Decision on Health Care
The Center for American Progress issued the following statement by President and CEO Neera Tanden in response to the District Court decision to destroy the Affordable Care Act:. This evening, Judge Reed O'Connor of the U.S. District Court for the Northern District of Texas, and former chief counsel to the Senate Republican whip, struck down the ent
12/15/18 - Cephalic Disorders Treatment Market: Latest Trends, Demand and Analysis 2028: Cephalic Disorders Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Review 2018 to 2028
Rockville, MD 12/15/2018 Cephalic disorders are congenital conditions characterized by damage or abnormal development of the nervous system. Anencephaly accounts for the largest share of cephalic disorders with almost 1,000 to 2,000 babies born with anencephaly each year in the U.S. The treatment for cephalic disorders includes drugs, surgery
12/15/18 - Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Substance Pegfilgrastim (atc: L03aa13) As Part Of A So-called Open-house Model. [TendersInfo (India)]
For the active substance pegfilgrastim, the aok rheinland-pfalz/ saarland- die gesundheitskasse offers rebate contracts to all interested pharmaceutical companies without a selection decision for the period up to the entry into force of exclusive contracts following a formal award procedure in accordance with the regulations of the 4th part of the
12/15/18 - CYNATA Gets Major Funding From NHMRC For Second Phase Clinical Trial In Osteoarthritis [Sport360]
Australian National Health and Medical Research Council will fund a major second phase of clinical trial in osteoarthritis for CYNATA THERAPEUTICS LIMITED. Cynata being a biotechnology company has its specialization in cell therapeutics. The company has a unique Cymerus technology which deals with the complexity and challenges of manufacturing the.
12/15/18 - Diabetes Treatment: Investment in Diabetes Management Software Growing: Fact.MR has announced the addition of the Nucleic Acid Extraction System Market Forecast, Trend Analysis & Competition Tracking - Global Review 2018 to 2027"report to their o
Rockville, MD 12/14/2018 The global market for diabetes management software has been expanding alongside the effort of the healthcare industry to induct the best facilities for treatment and care of diabetic patients. The robust healthcare industry in North America is expected to propel demand for diabetes management software across the regio
12/15/18 - Dr. Jin Kim, Internationally Influential Periodontist, Offers FDA-Cleared LANAP Laser Therapy for Periodontal Disease in Chino Hills, CA [Tehran Times (Iran)]
-Jin Y. Kim, a leading board-certified periodontist who has dedicated his career to learning and contributing to the latest in periodontal care welcomes people withperiodontal diseasein Chino Hills, CA, to take advantage of LANAP, the FDA- cleared laser gum therapy treatment he offers. When patients work with Dr. Kim to properly address their gum d
12/15/18 - DRAP fails to check corruption, unethical marketing practices by Pharma trade and industry
Drug Regulatory Authority of Pakistan which is one of the regulatory bodies and monitoring agencies to check corruption and unethical marketing practices by the pharma trade and industry has miserably failed to perform its duties. Farhat Moazam and approved by the Federal Government as well as Pakistan Medical and Dental Council many years ago but
12/15/18 - Equine Surgical Equipment Market to Increase at Steady Growth Rate 2018-2028: Equine Surgical Equipment Market Forecast, Trend Analysis & Competition Tracking - Global Review 2018 to 2028
Rockville, MD 12/14/2018 Equine medical equipment are medical tools used for surgical procedures of horses. Equine surgical equipment includes electrosurgical equipment, dental equipment, operating table, surgical lights, etc. As these equipment are designed as per the physical structure of equine, they help surgeons and nurses to complete th
12/15/18 - Generex Biotechnology Receives IND Approval From FDA For Phase II Combination Study Using AE37 Plus Keytruda (Pembrolizumab) For The Treatment Of Triple Negative Breast Cancer [Syrian Arab News Agency]
Generex Biotechnology Corporation today announced that the FDA had reviewed the companys investigational new drug application and given notification that the study can proceed. The study: A Phase II Clinical Trial of Pembrolizumab in Combination with the AE37 Peptide Vaccine in Patients with Metastatic Triple Negative Breast Cancer, is sponsored by
12/15/18 - Government to strengthen management of drug-making plants overseas [Sport360]
The Ministry of Food and Drug Safety said Thursday that it has revised the Pharmaceutical Affairs Law to set up a basis for the registration and inspection of drug-making plants in foreign countries. The agency also mandated that such factories must provide insurance for patients participating in the clinical trials. The amendment comes after the d
12/15/18 - Hammertoe Market Overview by Competitive Players, Segmentation, Region Wise Analysis, latest trends and Forecast to 2023
"Hammertoe Market" Market Research Future Announces the publication of its research report Global Hammertoe Market. By type, by diagnosis, by treatment, by end users- Global forecast till 2023. The U.S. hammertoe market is dependent on the legal and regulatory environment includes factors such as labelling standards, FDA classification rules etc
12/15/18 - Injectable Drug Delivery Market: In-Depth Evaluation on Growth, Share, Size and Trends Until the End of 20182028: Drug delivery refers to the approaches, technologies and systems used for the administration of drugs to patients.
Albany, NY 12/15/2018 In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine has included a new report titled " Injectable Drug Delivery Market" to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to tr
12/15/18 - Innovent reports positive results from two trials of IBI305 [Syrian Arab News Agency]
Innovent Biologics has reported positive results from two clinical trials of IBI305 after meeting the pre-defined primary endpoints of both studies. China- based Innovents IBI305 is a biosimilar of bevacizumab, which is a recombinant humanised anti-vascular endothelial growth factor monoclonal antibody developed for use as injection.
12/15/18 - It seems only private-sector workers are expected to make sacrifices for Gesy [Cyprus Mail]
IN THE last week, all the union representatives of employees of state hospitals had meetings with the head of the Organisation of State Health Services that will take over the running of the hospitals from next year, as part of the Gesy planning. Under Gesy, state hospitals will no longer be under the authority of the ministry of health but will be
12/15/18 - Janssen Submits Supplemental New Drug Application (sNDA) to FDA for XARELTO (rivaroxaban) to Prevent Venous Thromboembolism (VTE) in Acute Medically Ill Patients [Sport360]
The Janssen Pharmaceutical Companies of Johnson& Johnson announced today the submission of a supplemental New Drug Application for XARELTO to the U.S. Food and Drug Administration for the prevention of venous thromboembolism, or blood clots, in medically ill patients. "Despite being at high risk of VTE for up to six weeks when leaving the hospital
12/15/18 - Janssen Submits Supplemental New Drug Application to FDA for XARELTO (Rivaroxaban) to Prevent Venous Thromboembolism (VTE) in Acute Medically Ill Patients
Janssen Pharmaceutical Companies, a subsidiary of Johnson and Johnson, issued the following news release:. -If approved, this will add to the five existing VTE indications for XARELTO (R)- the most studied anticoagulant available to the most groups of patients. The Janssen Pharmaceutical Companies of Johnson& Johnson announced today the submission
12/15/18 - Liquid Crystal on Silicon (LCoS) Projectors Market Is a New Display Technology with a Fast Growing Market
Albany, NY 12/14/2018 Liquid crystal on silicon market is a new display technology with a fast growing market. The technology is used in various sectors medical, automation, defense, entertainment and so on. LCoS projectors are a combination of Digital Light Processing and Liquid Crystal Display technology.
12/15/18 - Medical Tourism Market is Set to Grow with 21.4% CAGR During the Forecast Period 2017-2023: MRFR
"Medical Tourism Market" Market Research Future Announces the publication of its research report Global Medical Tourism Market. by Treatment Type and Region- Global Forecast Till 2023. Medical tourism market is gaining precedence as it can provide an inexpensive treatment opportunity in contrast to that available in the developed countries.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415